The vicious cycle that trapped medical AI, and a domestic player has finally broken through.
A Chinese AI company, iFlytek, has reportedly broken a cycle that has hindered the progress of AI in the healthcare sector. Their new model, Spark Medical Large Model V3.5, has outperformed GPT-5.5 in several key medical evaluations and, more importantly, has demonstrated real-world clinical utility. Unlike other AI models that struggle with data standardization and integration into clinical workflows, iFlytek has built a self-reinforcing loop by establishing a wide range of clinical scenarios, accumulating vast amounts of standardized medical data, and developing models on domestic computing infrastructure. AI
IMPACT Establishes a new benchmark for AI in healthcare by demonstrating a viable path to overcome data and integration challenges.